Check out our most popular compounded medications! Get Started
Morphine Sulfate 300 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat various types of pain including chronic, cancer, postoperative, neuropathic, and arthritis pain. The slow release mechanism reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 300 mg Slow Release Capsules are a potent, long-acting opioid analgesic specifically formulated for the management of moderate to severe chronic pain. This unique formulation incorporates Methocel E4M, a type of controlled-release polymer, which is designed to gradually release the encapsulated medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, thereby reducing the frequency of dosing and improving patient compliance, particularly for medications that require a controlled and prolonged release profile.
The primary function of this formulation is to provide a steady, consistent release of the active ingredient, Morphine Sulfate, over a 12-hour period. However, it is crucial to note that this formulation is not intended for the treatment of acute pain.
Patients should be aware that Morphine Sulfate 300 mg Slow Release Capsules can cause side effects such as drowsiness, dizziness, and confusion. Therefore, it is advised not to operate heavy machinery or drive while on this medication. Furthermore, due to the nature of the active ingredient, there is a potential for addiction and abuse. Patients are strongly advised to take the medication strictly as prescribed by their healthcare provider.
Healthcare providers prescribing this formulation should be cognizant of its intended use for chronic pain management only. They should also be vigilant about the potential for addiction and abuse associated with this medication. It is recommended to monitor patients closely for signs of misuse or abuse to ensure the safe and appropriate use of Morphine Sulfate 300 mg Slow Release Capsules.
If you have any questions or concerns about Morphine Sulfate 300 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your medication needs.
Morphine Sulfate 300 mg Slow Release Capsules are formulated with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
These capsules may interact with other medications, including those used to treat depression, anxiety, pain, and sleep disorders. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements.
Patients should be aware of potential drug interactions with other opioids, benzodiazepines, alcohol, and other CNS depressants. Morphine Sulfate 300 mg Slow Release Capsules should not be taken if the patient is currently on monoamine oxidase inhibitors (MAOIs) or have taken them within the past 14 days.
There is a potential for increased risk of serotonin syndrome when taking Morphine Sulfate 300 mg Slow Release Capsules with other serotonergic medications. Similarly, there is a potential for increased risk of respiratory depression when taken with other CNS depressants. Patients should also be aware of the potential for increased risk of hypotension when taken with other medications that can cause hypotension.
There is a potential for increased risk of seizures when taking Morphine Sulfate 300 mg Slow Release Capsules with other medications that can cause seizures. Additionally, there is a potential for increased risk of gastrointestinal adverse effects when taken with other medications that can cause gastrointestinal adverse effects.
If you have any questions about potential interactions with Morphine Sulfate 300 mg Slow Release Capsules, please consult with your healthcare provider.
Morphine Sulfate 300 mg Slow Release Capsules are a potent, extended-release opioid medication designed to manage moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the encapsulated medication over an extended period. This slow-release mechanism provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The capsules are administered orally, typically once a day, and should be consumed with food. It is crucial to adhere to the prescribed dosage and frequency as directed by your healthcare provider. Overdosing or frequent intake can lead to serious health complications.
Morphine Sulfate 300 mg Slow Release Capsules are versatile in their application, providing relief from various pain conditions such as chronic pain, cancer-related pain, and post-operative pain. Additionally, they can be used to manage other conditions like persistent coughing and diarrhea. The medication functions by binding to opioid receptors in the brain and spinal cord, thereby reducing the perception of pain.
Like all medications, Morphine Sulfate 300 mg Slow Release Capsules can cause side effects, including but not limited to nausea, constipation, dizziness, and drowsiness. It is essential to communicate with your healthcare provider about any side effects you may experience. Furthermore, it is crucial to understand the potential for addiction and abuse associated with this medication, given its opioid nature.
If you have any queries or concerns about Morphine Sulfate 300 mg Slow Release Capsules, do not hesitate to reach out to your healthcare provider or pharmacist. They can provide comprehensive information about how this medication works and how it can assist in managing your pain effectively.
Morphine Sulfate 300 mg Slow Release Capsules are a potent analgesic formulation designed to provide sustained pain relief over an extended period. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredient, morphine sulfate. This slow-release mechanism offers prolonged therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled and extended release profile.
They can also be beneficial in managing dyspnea, or shortness of breath, in patients with advanced cancer. Additionally, Morphine Sulfate 300 mg Slow Release Capsules can be used to alleviate opioid-induced constipation and to reduce the severity of opioid withdrawal symptoms.
However, caution should be exercised when using Morphine Sulfate 300 mg Slow Release Capsules in patients with renal or hepatic impairment, as well as in patients with a history of substance abuse. Regular monitoring for signs of respiratory depression, sedation, and constipation is recommended. These capsules should not be used in patients with a known hypersensitivity to morphine or other opioids.
If you have any questions about the use of Morphine Sulfate 300 mg Slow Release Capsules for any of these indications, please do not hesitate to reach out for further information.
Morphine Sulfate 300 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to gradually release the active ingredient over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Slow release capsules offer several benefits. They provide sustained therapeutic effects, reduce the need for frequent dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
The Morphine Sulfate 300 mg Slow Release Capsules work by gradually releasing the active ingredient, morphine sulfate, over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M.
The frequency of dosing will depend on your doctor's prescription. However, due to the slow release nature of this medication, it is typically taken less frequently than other forms of the same medication.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up. Always follow your doctor's instructions.
Like all medications, Morphine Sulfate 300 mg Slow Release Capsules can have side effects. These can include nausea, vomiting, constipation, lightheadedness, dizziness, or drowsiness. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
No, you should not crush or break the capsules. Doing so can release all of the drug at once, increasing the risk of morphine overdose.
Always inform your doctor about all the medications you are currently taking, including prescription and non-prescription drugs, vitamins, and herbal supplements. Some medications may interact with Morphine Sulfate 300 mg Slow Release Capsules, affecting how it works or increasing the risk of side effects.
People with certain medical conditions, such as severe asthma or breathing problems, a blockage in the stomach or intestines, or a hypersensitivity to morphine, should not take Morphine Sulfate 300 mg Slow Release Capsules. Always consult your doctor before starting any new medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
